TrialInfection and immunity1996

Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

K L Kotloff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.